Key Record Dates
ClinicalTrials.gov Identifier: | NCT04039230 |
---|---|
Brief Title: | Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
First Submitted : | July 29, 2019 |
First Submitted that Met QC Criteria : | July 29, 2019 |
First Posted : | July 31, 2019 |
Last Update Submitted that Met QC Criteria : | March 28, 2024 |
Last Update Posted : | April 1, 2024 |